Form DEF 14C - Other definitive information statements:
SEC Accession No. 0001654954-20-003098
Filing Date
2020-03-24
Accepted
2020-03-24 15:57:20
Documents
1
Period of Report
2020-03-24
Effectiveness Date
2020-03-24

Document Format Files

Seq Description Document Type Size
1 DEF14C sbfm_def14c.htm DEF 14C 87845
  Complete submission text file 0001654954-20-003098.txt   89175
Mailing Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5
Business Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5 514-426-6161
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

EIN.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: DEF 14C | Act: 34 | File No.: 000-52898 | Film No.: 20738304
SIC: 8731 Services-Commercial Physical & Biological Research